Announced Thu, 25 Sept · 11:58 IST

Voting Results of 30th AGM of the Company in terms of Reg 44(3) of SEBI(LODR) Regulations, 2015 alongwith Consolidated Scrutinizer Report

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Omkar Pharmachem Limited held its 30th AGM on September 24, 2025, at Hotel Kanak, Ahmedabad, where all six resolutions were passed with overwhelming shareholder support. The resolutions included adoption of audited financial statements for FY2024-25, re-appointment of Managing Director Bhawani Shankar Goyal (retiring by rotation), appointment of two independent directors (Mrs. Surjeet Kaur and Mr. Anupam Kumar Mishra) via special resolutions, approval of material related party transactions, and appointment of secretarial auditors for five years. Every resolution received 100% votes in favor (1,937,573 votes), with zero votes against and zero invalid votes. Of the 3,629 shareholders on the record date, only 24 voted (6 via remote e-voting, 18 via poll at AGM), representing a low turnout of about 19.21% of outstanding shares. Notably, no promoter/promoter group shares were voted, and no video conferencing facility was arranged.

Likely market impact

All agenda items received unanimous shareholder approval with no dissent, reflecting smooth governance and no contentious issues at this AGM. The very low voting turnout and absence of promoter votes are worth noting but pose no immediate risk; the appointment of two new independent directors and approval of material related party transactions are routine governance actions for shareholders.